Levonordefrin

DB06707

small molecule approved

Deskripsi

Levonordefrin acts as a topical nasal decongestant and vasoconstrictor, most often used in dentistry.

Struktur Molekul 2D

Berat 183.2044
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

851 Data
Valsartan Levonordefrin may decrease the antihypertensive activities of Valsartan.
Ramipril Levonordefrin may decrease the antihypertensive activities of Ramipril.
Reserpine Levonordefrin may decrease the antihypertensive activities of Reserpine.
Remikiren Levonordefrin may decrease the antihypertensive activities of Remikiren.
Isradipine Levonordefrin may decrease the antihypertensive activities of Isradipine.
Olmesartan Levonordefrin may decrease the antihypertensive activities of Olmesartan.
Nitroprusside Levonordefrin may decrease the antihypertensive activities of Nitroprusside.
Diltiazem Levonordefrin may decrease the antihypertensive activities of Diltiazem.
Minoxidil Levonordefrin may decrease the antihypertensive activities of Minoxidil.
Treprostinil Levonordefrin may decrease the antihypertensive activities of Treprostinil.
Amlodipine Levonordefrin may decrease the antihypertensive activities of Amlodipine.
Nimodipine Levonordefrin may decrease the antihypertensive activities of Nimodipine.
Nisoldipine Levonordefrin may decrease the antihypertensive activities of Nisoldipine.
Fosinopril Levonordefrin may decrease the antihypertensive activities of Fosinopril.
Trandolapril Levonordefrin may decrease the antihypertensive activities of Trandolapril.
Lercanidipine Levonordefrin may decrease the antihypertensive activities of Lercanidipine.
Benazepril Levonordefrin may decrease the antihypertensive activities of Benazepril.
Bosentan Levonordefrin may decrease the antihypertensive activities of Bosentan.
Enalapril Levonordefrin may decrease the antihypertensive activities of Enalapril.
Candoxatril Levonordefrin may decrease the antihypertensive activities of Candoxatril.
Mecamylamine Levonordefrin may decrease the antihypertensive activities of Mecamylamine.
Losartan Levonordefrin may decrease the antihypertensive activities of Losartan.
Moexipril Levonordefrin may decrease the antihypertensive activities of Moexipril.
Lisinopril Levonordefrin may decrease the antihypertensive activities of Lisinopril.
Nitroglycerin Levonordefrin may decrease the antihypertensive activities of Nitroglycerin.
Metyrosine Levonordefrin may decrease the antihypertensive activities of Metyrosine.
Cryptenamine Levonordefrin may decrease the antihypertensive activities of Cryptenamine.
Perindopril Levonordefrin may decrease the antihypertensive activities of Perindopril.
Candesartan cilexetil Levonordefrin may decrease the antihypertensive activities of Candesartan cilexetil.
Fenoldopam Levonordefrin may decrease the antihypertensive activities of Fenoldopam.
Tadalafil Levonordefrin may decrease the antihypertensive activities of Tadalafil.
Eprosartan Levonordefrin may decrease the antihypertensive activities of Eprosartan.
Quinapril Levonordefrin may decrease the antihypertensive activities of Quinapril.
Telmisartan Levonordefrin may decrease the antihypertensive activities of Telmisartan.
Methyldopa Levonordefrin may decrease the antihypertensive activities of Methyldopa.
Irbesartan Levonordefrin may decrease the antihypertensive activities of Irbesartan.
Nitrendipine Levonordefrin may decrease the antihypertensive activities of Nitrendipine.
Deserpidine Levonordefrin may decrease the antihypertensive activities of Deserpidine.
Pentolinium Levonordefrin may decrease the antihypertensive activities of Pentolinium.
Trimethaphan Levonordefrin may decrease the antihypertensive activities of Trimethaphan.
Captopril Levonordefrin may decrease the antihypertensive activities of Captopril.
Epoprostenol Levonordefrin may decrease the antihypertensive activities of Epoprostenol.
Bepridil Levonordefrin may decrease the antihypertensive activities of Bepridil.
Hydralazine Levonordefrin may decrease the antihypertensive activities of Hydralazine.
Cilazapril Levonordefrin may decrease the antihypertensive activities of Cilazapril.
Saprisartan Levonordefrin may decrease the antihypertensive activities of Saprisartan.
Spirapril Levonordefrin may decrease the antihypertensive activities of Spirapril.
Mibefradil Levonordefrin may decrease the antihypertensive activities of Mibefradil.
Debrisoquine Levonordefrin may decrease the antihypertensive activities of Debrisoquine.
Sitaxentan Levonordefrin may decrease the antihypertensive activities of Sitaxentan.
Ambrisentan Levonordefrin may decrease the antihypertensive activities of Ambrisentan.
Diethylnorspermine Levonordefrin may decrease the antihypertensive activities of Diethylnorspermine.
Nilvadipine Levonordefrin may decrease the antihypertensive activities of Nilvadipine.
Pinacidil Levonordefrin may decrease the antihypertensive activities of Pinacidil.
Temocapril Levonordefrin may decrease the antihypertensive activities of Temocapril.
Riociguat Levonordefrin may decrease the antihypertensive activities of Riociguat.
Macitentan Levonordefrin may decrease the antihypertensive activities of Macitentan.
Hexamethonium Levonordefrin may decrease the antihypertensive activities of Hexamethonium.
Aliskiren Levonordefrin may decrease the antihypertensive activities of Aliskiren.
Nicorandil Levonordefrin may decrease the antihypertensive activities of Nicorandil.
Lacidipine Levonordefrin may decrease the antihypertensive activities of Lacidipine.
Manidipine Levonordefrin may decrease the antihypertensive activities of Manidipine.
Rauwolfia serpentina root Levonordefrin may decrease the antihypertensive activities of Rauwolfia serpentina root.
Enalaprilat Levonordefrin may decrease the antihypertensive activities of Enalaprilat.
Selexipag Levonordefrin may decrease the antihypertensive activities of Selexipag.
Angiotensin 1-7 Levonordefrin may decrease the antihypertensive activities of Angiotensin 1-7.
Imidapril Levonordefrin may decrease the antihypertensive activities of Imidapril.
BQ-123 Levonordefrin may decrease the antihypertensive activities of BQ-123.
Tetrahydropalmatine Levonordefrin may decrease the antihypertensive activities of Tetrahydropalmatine.
Dihydralazine Levonordefrin may decrease the antihypertensive activities of Dihydralazine.
Zofenopril Levonordefrin may decrease the antihypertensive activities of Zofenopril.
Guanoxan Levonordefrin may decrease the antihypertensive activities of Guanoxan.
Delapril Levonordefrin may decrease the antihypertensive activities of Delapril.
Vincamine Levonordefrin may decrease the antihypertensive activities of Vincamine.
Linsidomine Levonordefrin may decrease the antihypertensive activities of Linsidomine.
Guanoxabenz Levonordefrin may decrease the antihypertensive activities of Guanoxabenz.
Tolonidine Levonordefrin may decrease the antihypertensive activities of Tolonidine.
Endralazine Levonordefrin may decrease the antihypertensive activities of Endralazine.
Cadralazine Levonordefrin may decrease the antihypertensive activities of Cadralazine.
Bietaserpine Levonordefrin may decrease the antihypertensive activities of Bietaserpine.
Guanazodine Levonordefrin may decrease the antihypertensive activities of Guanazodine.
Methoserpidine Levonordefrin may decrease the antihypertensive activities of Methoserpidine.
Guanoclor Levonordefrin may decrease the antihypertensive activities of Guanoclor.
Candesartan Levonordefrin may decrease the antihypertensive activities of Candesartan.
Dexniguldipine Levonordefrin may decrease the antihypertensive activities of Dexniguldipine.
Tocopherylquinone Levonordefrin may decrease the antihypertensive activities of Tocopherylquinone.
Benazeprilat Levonordefrin may decrease the antihypertensive activities of Benazeprilat.
Fosinoprilat Levonordefrin may decrease the antihypertensive activities of Fosinoprilat.
Ramiprilat Levonordefrin may decrease the antihypertensive activities of Ramiprilat.
Perindoprilat Levonordefrin may decrease the antihypertensive activities of Perindoprilat.
Quinaprilat Levonordefrin may decrease the antihypertensive activities of Quinaprilat.
Felodipine Levonordefrin may decrease the antihypertensive activities of Felodipine.
Levamlodipine Levonordefrin may decrease the antihypertensive activities of Levamlodipine.
Azilsartan medoxomil Levonordefrin may decrease the antihypertensive activities of Azilsartan medoxomil.
Diazoxide Levonordefrin may decrease the antihypertensive activities of Diazoxide.
Desmopressin The risk or severity of hypertension can be increased when Desmopressin is combined with Levonordefrin.
Cyclosporine The risk or severity of hypertension can be increased when Cyclosporine is combined with Levonordefrin.
Icosapent The risk or severity of hypertension can be increased when Icosapent is combined with Levonordefrin.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Levonordefrin.
Bethanidine Levonordefrin may decrease the antihypertensive activities of Bethanidine.

Target Protein

Alpha-1D adrenergic receptor ADRA1D
Alpha-1B adrenergic receptor ADRA1B
Alpha-1A adrenergic receptor ADRA1A
Alpha-2 adrenergic receptors ADRA2A

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 18 • International brands: 2
Produk
  • 2% Polocaine Dental With Levonordefrin 1:20,000
    Solution • - • Infiltration • Canada • Approved
  • Carbocaine 2% With Neo-cobefrin
    Solution • - • Infiltration • Canada • Approved
  • Carbocaine 2% With Neo-cobefrin
    Solution • - • Infiltration • Canada • Approved
  • Carbocaine 2% With Neo-cobefrin
    Solution • - • Infiltration • Canada • Approved
  • Carbocaine with Neo-Cobefrin
    Injection, solution • - • Subcutaneous • US • Generic • Approved
  • Carbocaine with Neo-Cobefrin
    Injection, solution • - • Subcutaneous • US • Generic • Approved
  • Isocaine HCl Inj 2%
    Solution • - • Infiltration • Canada • Approved
  • Isocaine with Levonordefrin
    Injection, solution • - • Subcutaneous • US • Approved
Menampilkan 8 dari 18 produk.
International Brands
  • Neo-Cobefrin
  • Nordefrin

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul